Question

What research stage is stem-cell therapy for Intellectual Disability at?

4 of 27 registered records carry a Phase 3 or Phase 4 label. The rest sit at earlier phases or carry no phase label at all. Snapshot 2026-08-29.

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

Phase distribution

Phase labelRecordsShare
Not applicable1235%
Phase 21132%
Phase 1721%
Phase 3412%

What the phase mix means for Intellectual Disability

Phase distribution across an umbrella category cannot be interpreted meaningfully. Check the underlying condition of any cited study before treating it as relevant.

The later-phase studies themselves

StudyPhaseStatusPlanned nLead sponsorStart
NCT00176904 — Stem Cell Transplant for Inborn Errors of MetabolismPhase 2, Phase 3Completed135Masonic Cancer Center, University of Minnesota1995-01
NCT00654433 — ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic DiseasesPhase 3Terminated40Aldagen2008-03
NCT03852498 — A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)Phase 3Completed35Genetix Biotherapeutics Inc.2019-01-24
NCT01896102 — A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral AdrenoleukodystPhase 2, Phase 3Completed32Genetix Biotherapeutics Inc.2013-08-21

How to read phase labels

Early phases exist to find harm and set a dose. They are not built to detect benefit, and they routinely produce encouraging-looking numbers that later trials fail to reproduce. Only a confirmatory design with a comparison arm can separate the intervention from everything else happening to a patient.

Median planned enrolment across sampled studies here is 38 participants. Small single-arm studies can flag safety problems; they cannot separate a treatment effect from natural fluctuation, placebo response or regression to the mean.

The largest studies by planned enrolment

Size is a crude proxy for what a study can detect, but it separates a serious attempt from a case series presented as evidence.

StudyPhaseStatusPlanned nLead sponsorStart
NCT04090268 — Precision Exercise in Children With Malignant Hemopathiesn/aUnknown380University of Milano Bicocca2017-04-03
NCT04122742 — Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.n/aUnknown154University Hospital, Bordeaux2019-10-08
NCT02171104 — MT2013-31: Allo HCT for Metabolic Disorders and Severe OsteopetrosisPhase 2Active Not Recruiting149Masonic Cancer Center, University of Minnesota2014-07-10
NCT00176904 — Stem Cell Transplant for Inborn Errors of MetabolismPhase 2, Phase 3Completed135Masonic Cancer Center, University of Minnesota1995-01
NCT01962415 — Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCTPhase 2Recruiting100Paul Szabolcs2014-02-04

Frequently asked

What research stage is stem-cell therapy for Intellectual Disability at?

4 of 27 records are labelled Phase 3 or 4 (2026-08-29).

Is a Phase 3 trial proof that it works?

No — it is a design capable of testing that question. Proof depends on the reported result, replication, and whether the outcome measured matters to patients.

Why do so many records have no phase?

Observational studies and some cell-therapy protocols are registered without a phase label. It is a registry field, not a quality rating.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads